Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹7.31 Cr₹10 Cr--₹0.83 Cr

What is the latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of BAFNA PHARMACEUTICALS is ₹7.31 Cr based on Mar2025 Standalone results.
Year Capital Work in Progress
Mar2025₹7.31 Cr
Mar2024₹10 Cr
Mar2023-
Mar2022-
Mar2021₹0.83 Cr

How is Capital Work in Progress of BAFNA PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹7.31 Cr
-30.33
Mar2024 ₹10 Cr
0
Mar2023 -
0
Mar2022 -
-100.00
Mar2021 ₹0.83 Cr -

Compare Capital Work in Progress of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹267.7 Cr 9.8% 2.5% 56.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,492.9 Cr -4.6% -8% -16.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

9.8%

2.5%

56.4%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses